Location History:
- Kanagawa, JP (2014 - 2017)
- Fujisawa, JP (2020)
Company Filing History:
Years Active: 2014-2020
Title: Taisuke Katoh: Innovator in Pharmaceutical Compounds
Introduction
Taisuke Katoh is a prominent inventor based in Kanagawa, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address various medical conditions. With a total of 3 patents to his name, Katoh's work is recognized for its potential impact on healthcare.
Latest Patents
Katoh's latest patents include a heterocyclic compound that exhibits RIP1 kinase inhibitory action. This compound is particularly useful for the prophylaxis or treatment of several diseases, including Gaucher's disease, Niemann-Pick disease, inflammatory bowel disease, multiple sclerosis, chronic kidney disease, acute kidney injury, acute hepatic failure, autoimmune hepatitis, hepatitis B, hepatitis C, alcohol steatohepatitis, and non-alcohol steatohepatitis. The invention is represented by a specific formula, with detailed definitions provided in the specification.
Another notable patent involves cyclic compounds that have a Toll-like receptor 4 (TLR4) signaling inhibitory action. These compounds are designed as preventive and therapeutic drugs for inflammatory diseases and central nervous system disorders, including chemotherapy-induced peripheral neuropathy (CIPN), chemotherapy-induced neuropathic pain (CINP), liver injury, and ischemia-reperfusion injury (IRI). Similar to the previous patent, this invention is also represented by a specific formula, with further explanations in the specification.
Career Highlights
Taisuke Katoh is currently associated with Takeda Pharmaceutical Company Limited, a leading global biopharmaceutical company. His work at Takeda has allowed him to focus on innovative research and development in the pharmaceutical sector. His contributions have been instrumental in advancing therapeutic options for various diseases.
Collaborations
Throughout his career, Katoh has collaborated with notable colleagues, including Morihisa Saitoh and Shigemitsu Matsumoto. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.
Conclusion
Taisuke Katoh's work exemplifies the importance of innovation in the pharmaceutical industry. His patents reflect a commitment to addressing critical health challenges through scientific research and development. His contributions continue to pave the way for new therapeutic solutions.